Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06477796 · ClinicalTrials.gov registry record · NA

Improving Sleep in Veterans With the Polytrauma Clinical Triad

A NA study of Chronic Pain and Post Traumatic Stress Disorder, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
96
Enrollment target
1
Study location

NCT06477796: Recruiting NA study of Chronic Pain and Post Traumatic Stress Disorder, sponsored by VA Office of Research and Development.

NCT06477796 is a NA study of Chronic Pain and Post Traumatic Stress Disorder that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 96 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06477796, a NA study of Chronic Pain and Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
96 participants
Enrollment target
1
Study location

Study Summary

The "polytrauma clinical triad" (PCT), a highly disabling constellation of factors, is defined by the coexistence of traumatic brain injury, post-traumatic stress disorder, and chronic pain. Veterans with the PCT are medically complex, often refractory to conventional therapies, and suffer from additional related chronic sequela. Notably, sleep disturbances and cognitive impairment, which the investigators hypothesize are significant contributing factors to these functional impairments and an impediment toward rehabilitation. Thus, the investigators' research aims to intervene "at the level of sleep", and by improving sleep, improve these interconnected, disabling, and difficult to treat enduring complexities associated with the PCT - ultimately to improve Veteran quality of life, functional independence, and restorative function. The investigators predict that the proposed intervention, morning bright light therapy, which is cost-effective, rapidly deployable and home-based, will be effective in improving sleep and overall PCT symptom management, thereby, resulting in a measurable and impactful improvement in quality of life.

Primary Outcome

Sleep efficiency is defined by the total time asleep divided by total time spent in bed

Interventions

  • DEVICE Morning Bright Light Therapy
  • DEVICE Negative Ion Generator

Study Locations (1)

Oregon

  • VA Portland Health Care System, Portland, OR - Portland

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2025-05-01
Est. Completion 2028-09-29
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT06477796 shows while recruiting

NCT06477796 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (88% lower).

The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Morning Bright Light Therapy is the first listed.

NCT06477796 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT06477796 about?

NCT06477796 is a clinical study titled "Improving Sleep in Veterans With the Polytrauma Clinical Triad". The "polytrauma clinical triad" (PCT), a highly disabling constellation of factors, is defined by the coexistence of traumatic brain injury, post-traumatic stress disorder, and chronic pain. Veterans with the PCT are medically complex, often refractory to conventional therapies, and suffer from addi...

What is the current status of trial NCT06477796?

This trial is currently recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2025-05-01. Estimated completion is 2028-09-29.

What conditions does trial NCT06477796 study?

This clinical trial studies the following conditions: Chronic Pain, Post Traumatic Stress Disorder, Traumatic Brain Injury.

What interventions are being tested in trial NCT06477796?

The interventions under investigation include: Morning Bright Light Therapy (DEVICE), Negative Ion Generator (DEVICE).

Who is sponsoring clinical trial NCT06477796?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06477796 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06477796's enrollment target sits among peer trials

96 140th of 301 higher than 161 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03401762 · 96 participants · NA

    Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke

  • NCT03471260 · 96 participants · Phase 1

    Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

  • NCT03549559 · 96 participants · NA

    Imaging Histone Deacetylase in the Heart

  • NCT03841058 · 96 participants · Phase 2

    Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06477796, the US trial registry maintained by the National Library of Medicine. NCT06477796 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.